Yield10 Bioscience Inc
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, … Read more
Market Cap & Net Worth: Yield10 Bioscience Inc (YTEN)
Yield10 Bioscience Inc (NASDAQ:YTEN) has a market capitalization of $10.39K ($10.39K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #45309 globally and #14261 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Yield10 Bioscience Inc's stock price $0.02 by its total outstanding shares 692683 (692.68K).
Yield10 Bioscience Inc Market Cap History: 2015 to 2025
Yield10 Bioscience Inc's market capitalization history from 2015 to 2025. Data shows change from $10.24 Billion to $10.39K (-78.22% CAGR).
Yield10 Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Yield10 Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
66.30x
Yield10 Bioscience Inc's market cap is 66.30 times its annual revenue
0.23x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $10.24 Billion | $2.59 Million | -$23.68 Million | 3947.81x | N/A |
| 2016 | $2.33 Billion | $1.16 Million | -$7.60 Million | 2008.12x | N/A |
| 2017 | $1.18 Billion | $944.00K | -$9.40 Million | 1246.83x | N/A |
| 2018 | $551.93 Million | $556.00K | -$9.19 Million | 992.68x | N/A |
| 2019 | $114.04 Million | $806.00K | -$12.96 Million | 141.49x | N/A |
| 2020 | $96.09 Million | $799.00K | -$10.21 Million | 120.26x | N/A |
| 2021 | $81.79 Million | $614.00K | -$11.03 Million | 133.21x | N/A |
| 2022 | $27.75 Million | $450.00K | -$13.57 Million | 61.68x | N/A |
| 2023 | $3.98 Million | $60.00K | -$14.46 Million | 66.30x | N/A |
Competitor Companies of YTEN by Market Capitalization
Companies near Yield10 Bioscience Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Yield10 Bioscience Inc by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Yield10 Bioscience Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Yield10 Bioscience Inc's market cap moved from $10.24 Billion to $ 10.39K, with a yearly change of -78.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $10.39K | -96.25% |
| 2024 | $277.07K | -93.04% |
| 2023 | $3.98 Million | -85.67% |
| 2022 | $27.75 Million | -66.07% |
| 2021 | $81.79 Million | -14.88% |
| 2020 | $96.09 Million | -15.74% |
| 2019 | $114.04 Million | -79.34% |
| 2018 | $551.93 Million | -53.11% |
| 2017 | $1.18 Billion | -49.43% |
| 2016 | $2.33 Billion | -77.27% |
| 2015 | $10.24 Billion | -- |
End of Day Market Cap According to Different Sources
On Feb 20th, 2026 the market cap of Yield10 Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.39K USD |
| MoneyControl | $10.39K USD |
| MarketWatch | $10.39K USD |
| marketcap.company | $10.39K USD |
| Reuters | $10.39K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.